stockrowLeMaitre Vascular, Inc. (LMAT) vs Pulse Biosciences, Inc (PLSE)
- LeMaitre Vascular, Inc. LMAT 82.87 −5.74%
- Pulse Biosciences, Inc PLSE 53.15 −6.85%
LeMaitre Vascular, Inc. and Pulse Biosciences, Inc are both Medical Instruments & Supplies companies. Pulse Biosciences, Inc is the larger, with a market value of $3.9B against $1.9B — 2.0× the size. Pulse Biosciences, Inc has negative trailing earnings, so its P/E is not meaningful; LeMaitre Vascular, Inc. trades at 29.7×. Pulse Biosciences, Inc grew revenue faster over the last twelve months: 90.1% against 11.8%. LeMaitre Vascular, Inc. has the higher net margin (23.5% vs −5,609.4%) and the higher return on invested capital (22.1% vs −37.0%). Across the 18 metrics below, LeMaitre Vascular, Inc. leads on 16 and Pulse Biosciences, Inc on 2.
Valuation
Profitability
| Metric | LMAT | PLSE | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 72.04% | 26.77% | 53.60% |
| Operating margin | 27.73% | (5,821.08%) | 1.97% |
| Net margin | 23.51% | (5,609.44%) | 0.00% |
| Free cash flow margin | 24.87% | (14,462.52%) | 2.36% |
| Return on equity | 15.62% | (60.67%) | 0.00% |
| Return on assets | 10.10% | (54.01%) | 0.00% |
| Return on invested capital | 22.05% | (37.01%) | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack